Abiopharma

Pfizer Inc. - Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance

Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance

Organigram Reports Record Fourth Quarter and Fiscal 2025 Results

Warrant Prospectus Related to Convertible Note Agreements

Grifols Communication - Grifols obtains approval from the EMA for the entire value chain of Grifols Egypt

Subcutaneous Saphnelo approved in EU

Hyphens Notification - Change of Directors Interest - Tan Kia King (12 Dec 2025)

Zoetis - Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering

Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering

Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline